Zhongzhu Historical Cash Flow

600568 Stock   1.57  0.01  0.64%   
Analysis of Zhongzhu Medical cash flow over time is an excellent tool to project Zhongzhu Medical Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 97.8 K or Capital Expenditures of 25.9 M as it is a great indicator of Zhongzhu Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Zhongzhu Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zhongzhu Medical Holdings is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhongzhu Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Zhongzhu Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Zhongzhu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Zhongzhu's non-liquid assets can be easily converted into cash.

Zhongzhu Medical Cash Flow Chart

At present, Zhongzhu Medical's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 80.9 M, whereas Other Cashflows From Financing Activities is projected to grow to (31.4 M).

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Zhongzhu Medical Holdings to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Zhongzhu Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Change In Working Capital

The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.
Most accounts from Zhongzhu Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Zhongzhu Medical Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhongzhu Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Zhongzhu Medical's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 80.9 M, whereas Other Cashflows From Financing Activities is projected to grow to (31.4 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures63.0M26.0M27.3M25.9M
Dividends Paid1.1M105.6K103.0K97.8K

Zhongzhu Medical cash flow statement Correlations

-0.05-0.01-0.6-0.060.220.590.290.13-0.59-0.05-0.030.010.11-0.03-0.01
-0.05-0.110.56-0.43-0.04-0.090.030.130.23-0.31-0.21-0.010.45-0.060.1
-0.01-0.11-0.14-0.310.21-0.42-0.32-0.96-0.23-0.180.57-0.14-0.590.17-0.15
-0.60.56-0.140.07-0.48-0.29-0.290.050.37-0.08-0.150.060.25-0.060.08
-0.06-0.43-0.310.07-0.180.14-0.080.2-0.080.25-0.060.160.04-0.06-0.12
0.22-0.040.21-0.48-0.180.210.73-0.150.20.42-0.270.440.22-0.430.39
0.59-0.09-0.42-0.290.140.210.70.49-0.270.6-0.640.580.56-0.590.57
0.290.03-0.32-0.29-0.080.730.70.350.240.73-0.770.760.69-0.760.77
0.130.13-0.960.050.2-0.150.490.350.220.19-0.610.150.6-0.220.19
-0.590.23-0.230.37-0.080.2-0.270.240.220.39-0.540.440.49-0.490.47
-0.05-0.31-0.18-0.080.250.420.60.730.190.39-0.770.930.56-0.90.87
-0.03-0.210.57-0.15-0.06-0.27-0.64-0.77-0.61-0.54-0.77-0.85-0.940.89-0.87
0.01-0.01-0.140.060.160.440.580.760.150.440.93-0.850.74-0.980.94
0.110.45-0.590.250.040.220.560.690.60.490.56-0.940.74-0.780.75
-0.03-0.060.17-0.06-0.06-0.43-0.59-0.76-0.22-0.49-0.90.89-0.98-0.78-0.96
-0.010.1-0.150.08-0.120.390.570.770.190.470.87-0.870.940.75-0.96
Click cells to compare fundamentals

Zhongzhu Medical Account Relationship Matchups

Zhongzhu Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory154.6M89.8M(20.0M)(5.0M)84.8M90.8M
Other Cashflows From Financing Activities(3.6M)(12.3M)(71.9M)(36.7M)(33.1M)(31.4M)
Dividends Paid11.2M4.4M1.1M105.6K103.0K97.8K
Capital Expenditures765.6M99.7M63.0M26.0M27.3M25.9M
Total Cash From Operating Activities614.6M248.2M94.0M25.5M2.8M2.6M
Net Income(369.5M)3.2M(211.3M)(799.2M)(343.9M)(326.7M)
Total Cash From Financing Activities(171.1M)(116.3M)(107.2M)(37.1M)(33.4M)(31.7M)
Total Cashflows From Investing Activities(822.5M)157.7M(154.0M)(121.9M)(109.7M)(115.2M)
Change To Account Receivables305.2M135.2M127.5M754.7K867.9K824.6K
Other Cashflows From Investing Activities206.1M(43.8M)36.3M1.3M1.2M1.1M
Investments(266M)200M(108.7M)(97.8M)(40.4M)(42.4M)
Change In Cash(379.1M)289.6M(167.2M)(133.4M)(49.1M)(51.6M)
Net Borrowings(156.3M)(99.6M)(34.1M)(241.9K)(278.2K)(292.1K)
Depreciation71.6M82.5M101.7M99.4M79.6M80.9M
Change To Netincome467.2M(43.5M)157.5M620.3M713.4M365.7M
Change To Liabilities158.9M(27.1M)(69.1M)102.1M117.4M123.3M
End Period Cash Flow404.9M694.5M527.3M393.9M344.8M654.9M
Free Cash Flow(151.1M)148.4M31.0M(429.3K)(24.5M)(25.7M)
Change In Working Capital662.9M205.0M38.4M97.8M6.1M5.8M
Begin Period Cash Flow784.0M404.9M694.5M527.3M393.9M709.1M
Other Non Cash Items14.2M13.1M23.8M22.0M18.0M9.8M

Currently Active Assets on Macroaxis

Other Information on Investing in Zhongzhu Stock

The Cash Flow Statement is a financial statement that shows how changes in Zhongzhu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Zhongzhu's non-liquid assets can be easily converted into cash.